EV-201: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy Meeting Abstract
| Authors: | Rosenberg, J. E.; Balar, A.; O'Donnell, P. H.; Heath, E. I.; Hahn, N. M.; Cavazos, N. M.; Melhem-Bertrandt, A.; Petrylak, D. P. |
| Abstract Title: | EV-201: A single-arm, open-label, multicenter study of enfortumab vedotin for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor therapy |
| Meeting Title: | 43rd ESMO Congress (ESMO 2018) |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 8 |
| Meeting Dates: | 2018 Oct 19-23 |
| Meeting Location: | Munich, Germany |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-10-01 |
| Start Page: | mdy283.127 |
| Language: | English |
| ACCESSION: | WOS:000459277302101 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy283.127 |
| Notes: | Meeting Abstract: 918TiP -- Appears on pages viii326-viii327 of the abstract book -- Source: Wos |
